+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Blotting Systems - Global Strategic Business Report

  • PDF Icon

    Report

  • 193 Pages
  • October 2024
  • Region: Global
  • Global Industry Analysts, Inc
  • ID: 5139572
The global market for Blotting Systems was estimated at US$1.1 Billion in 2023 and is projected to reach US$1.6 Billion by 2030, growing at a CAGR of 5.4% from 2023 to 2030. This comprehensive report provides an in-depth analysis of market trends, drivers, and forecasts, helping you make informed business decisions.

Global Blotting Systems Market - Key Trends and Drivers Summarized

Why Are Blotting Systems Integral to Molecular Biology Research?

Blotting systems are fundamental tools in molecular biology, playing a critical role in the detection and analysis of biomolecules such as DNA, RNA, and proteins. Techniques like Western blotting, Southern blotting, and Northern blotting enable researchers to transfer and immobilize nucleic acids or proteins onto a membrane for further analysis, allowing for the identification, quantification, and characterization of specific molecules within a complex mixture. These systems are indispensable in various applications, including genetic research, diagnostics, and drug development, where precise molecular analysis is crucial. The ability of blotting systems to detect low-abundance molecules with high specificity and sensitivity makes them invaluable for researchers seeking to understand the molecular underpinnings of diseases and develop targeted therapies.

How Are Technological Advancements Shaping the Future of Blotting Systems?

The field of blotting systems is evolving rapidly, driven by technological advancements that are enhancing the efficiency, sensitivity, and throughput of these techniques. Innovations such as automated blotting systems are streamlining the blotting process, reducing manual labor and minimizing errors, which is particularly beneficial in high-throughput laboratories. The development of enhanced chemiluminescence and fluorescence detection methods has significantly improved the sensitivity of blotting assays, enabling the detection of even minute quantities of target molecules. Additionally, the integration of digital imaging and analysis software is providing researchers with more accurate and reproducible data, facilitating better interpretation of results. These technological improvements are making blotting systems more accessible and effective, thereby expanding their applications in both research and clinical settings.

What Challenges and Market Dynamics Are Influencing the Blotting Systems Industry?

The blotting systems market is influenced by a range of challenges and dynamic market forces. One of the key challenges is the need for systems that can deliver high sensitivity and specificity while being cost-effective and easy to use. This has driven companies to invest in the development of more robust and user-friendly systems that can meet the diverse needs of researchers across different fields. Another significant challenge is the competition from alternative technologies, such as mass spectrometry and next-generation sequencing, which offer high-throughput and multiplexing capabilities. Despite these challenges, blotting systems remain a staple in molecular biology due to their established protocols, versatility, and the deep-rooted familiarity of these techniques among researchers. Market dynamics are also shaped by the growing demand for personalized medicine and the need for precise molecular diagnostics, which continue to drive the adoption of advanced blotting technologies.

What Factors Are Driving the Growth of the Blotting Systems Market?

The growth in the blotting systems market is driven by several factors, including the increasing demand for proteomics and genomics research, which relies heavily on blotting techniques for the analysis of proteins and nucleic acids. The expanding scope of biomedical research, particularly in the fields of cancer, infectious diseases, and genetic disorders, is also fueling the need for advanced blotting systems that can provide detailed molecular insights. Additionally, the rise of personalized medicine, which requires precise molecular characterization of patient samples, is driving the adoption of more sophisticated blotting technologies. Technological advancements, such as the development of high-sensitivity detection methods and automated systems, are further propelling market growth by making blotting assays more efficient and accessible to a broader range of laboratories. Moreover, the increasing emphasis on reproducibility and accuracy in scientific research is enhancing the demand for high-quality blotting systems that can deliver reliable results. As research continues to push the boundaries of molecular biology, the need for advanced and versatile blotting systems is expected to grow, driving further innovation and expansion in the market.

Key Insights:

  • Market Growth: Understand the significant growth trajectory of the Pharma & Biotech Companies End-Use segment, which is expected to reach US$776.2 Million by 2030 with a CAGR of a 6.0%. The Academic & Research Institutes End-Use segment is also set to grow at 5.4% CAGR over the analysis period.
  • Regional Analysis: Gain insights into the U.S. market, which was estimated at $297.5 Million in 2023, and China, forecasted to grow at an impressive 8.5% CAGR to reach $379.2 Million by 2030. Discover growth trends in other key regions, including Japan, Canada, Germany, and the Asia-Pacific.

Why You Should Buy This Report:

  • Detailed Market Analysis: Access a thorough analysis of the Global Blotting Systems Market, covering all major geographic regions and market segments.
  • Competitive Insights: Get an overview of the competitive landscape, including the market presence of major players across different geographies.
  • Future Trends and Drivers: Understand the key trends and drivers shaping the future of the Global Blotting Systems Market.
  • Actionable Insights: Benefit from actionable insights that can help you identify new revenue opportunities and make strategic business decisions.

Key Questions Answered:

  • How is the Global Blotting Systems Market expected to evolve by 2030?
  • What are the main drivers and restraints affecting the market?
  • Which market segments will grow the most over the forecast period?
  • How will market shares for different regions and segments change by 2030?
  • Who are the leading players in the market, and what are their prospects?

Report Features:

  • Comprehensive Market Data: Independent analysis of annual sales and market forecasts in US$ Million from 2023 to 2030.
  • In-Depth Regional Analysis: Detailed insights into key markets, including the U.S., China, Japan, Canada, Europe, Asia-Pacific, Latin America, Middle East, and Africa.
  • Company Profiles: Coverage of major players such as Advansta Inc., Bio-Rad Laboratories, Inc., Bio-Techne Coporation, and more.
  • Complimentary Updates: Receive free report updates for one year to keep you informed of the latest market developments.

Select Competitors (Total 44 Featured):

  • Advansta Inc.
  • Bio-Rad Laboratories, Inc.
  • Bio-Techne Coporation
  • Cell Signaling Technology, Inc.
  • F. Hoffmann-La Roche AG
  • GE Healthcare
  • LI-COR, Inc. (LI-COR Biosciences)
  • Merck KgaA
  • PerkinElmer, Inc.
  • Thermo Fisher Scientific, Inc.

Table of Contents

I. METHODOLOGYII. EXECUTIVE SUMMARY
1. MARKET OVERVIEW
  • Influencer Market Insights
  • World Market Trajectories
  • Blotting Systems - Global Key Competitors Percentage Market Share in 2024 (E)
  • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2024 (E)
2. FOCUS ON SELECT PLAYERS
3. MARKET TRENDS & DRIVERS
  • Increasing Demand for Protein Analysis Propels Growth of Blotting Systems
  • Advancements in Imaging Technologies Drive Adoption of Automated Blotting Systems
  • Rising Research in Proteomics Expands the Addressable Market Opportunity
  • Shift Towards High-Throughput Blotting Systems Strengthens the Business Case for Innovation
  • Growing Focus on Precision Medicine Throws the Spotlight on Advanced Blotting Techniques
  • Rising Incidence of Chronic Diseases Spurs Demand for Reliable Diagnostic Tools
  • Here`s the Story: How Automation in Laboratories Drives Adoption of Blotting Systems
  • Integration of Blotting Systems with Digital Platforms Generates Competitive Advantages
  • Here`s How Environmental and Food Safety Testing Spurs the Need for Efficient Blotting Systems
4. GLOBAL MARKET PERSPECTIVE
  • Table 1: World Blotting Systems Market Analysis of Annual Sales in US$ Thousand for Years 2014 through 2030
  • Table 2: World Recent Past, Current & Future Analysis for Blotting Systems by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
  • Table 3: World Historic Review for Blotting Systems by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • Table 4: World 16-Year Perspective for Blotting Systems by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2014, 2024 & 2030
  • Table 5: World Recent Past, Current & Future Analysis for Pharma & Biotech Companies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
  • Table 6: World Historic Review for Pharma & Biotech Companies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • Table 7: World 16-Year Perspective for Pharma & Biotech Companies by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
  • Table 8: World Recent Past, Current & Future Analysis for Academic & Research Institutes by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
  • Table 9: World Historic Review for Academic & Research Institutes by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • Table 10: World 16-Year Perspective for Academic & Research Institutes by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
  • Table 11: World Recent Past, Current & Future Analysis for Hospitals & Diagnostic Laboratories by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
  • Table 12: World Historic Review for Hospitals & Diagnostic Laboratories by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • Table 13: World 16-Year Perspective for Hospitals & Diagnostic Laboratories by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
III. MARKET ANALYSIS
UNITED STATES
  • Blotting Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2024 (E)
  • Table 14: USA Recent Past, Current & Future Analysis for Blotting Systems by End-Use - Pharma & Biotech Companies, Academic & Research Institutes and Hospitals & Diagnostic Laboratories - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • Table 15: USA Historic Review for Blotting Systems by End-Use - Pharma & Biotech Companies, Academic & Research Institutes and Hospitals & Diagnostic Laboratories Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • Table 16: USA 16-Year Perspective for Blotting Systems by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Academic & Research Institutes and Hospitals & Diagnostic Laboratories for the Years 2014, 2024 & 2030
CANADA
  • Table 17: Canada Recent Past, Current & Future Analysis for Blotting Systems by End-Use - Pharma & Biotech Companies, Academic & Research Institutes and Hospitals & Diagnostic Laboratories - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • Table 18: Canada Historic Review for Blotting Systems by End-Use - Pharma & Biotech Companies, Academic & Research Institutes and Hospitals & Diagnostic Laboratories Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • Table 19: Canada 16-Year Perspective for Blotting Systems by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Academic & Research Institutes and Hospitals & Diagnostic Laboratories for the Years 2014, 2024 & 2030
JAPAN
  • Blotting Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2024 (E)
  • Table 20: Japan Recent Past, Current & Future Analysis for Blotting Systems by End-Use - Pharma & Biotech Companies, Academic & Research Institutes and Hospitals & Diagnostic Laboratories - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • Table 21: Japan Historic Review for Blotting Systems by End-Use - Pharma & Biotech Companies, Academic & Research Institutes and Hospitals & Diagnostic Laboratories Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • Table 22: Japan 16-Year Perspective for Blotting Systems by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Academic & Research Institutes and Hospitals & Diagnostic Laboratories for the Years 2014, 2024 & 2030
CHINA
  • Blotting Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2024 (E)
  • Table 23: China Recent Past, Current & Future Analysis for Blotting Systems by End-Use - Pharma & Biotech Companies, Academic & Research Institutes and Hospitals & Diagnostic Laboratories - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • Table 24: China Historic Review for Blotting Systems by End-Use - Pharma & Biotech Companies, Academic & Research Institutes and Hospitals & Diagnostic Laboratories Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • Table 25: China 16-Year Perspective for Blotting Systems by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Academic & Research Institutes and Hospitals & Diagnostic Laboratories for the Years 2014, 2024 & 2030
EUROPE
  • Blotting Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2024 (E)
  • Table 26: Europe Recent Past, Current & Future Analysis for Blotting Systems by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
  • Table 27: Europe Historic Review for Blotting Systems by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • Table 28: Europe 16-Year Perspective for Blotting Systems by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2014, 2024 & 2030
  • Table 29: Europe Recent Past, Current & Future Analysis for Blotting Systems by End-Use - Pharma & Biotech Companies, Academic & Research Institutes and Hospitals & Diagnostic Laboratories - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • Table 30: Europe Historic Review for Blotting Systems by End-Use - Pharma & Biotech Companies, Academic & Research Institutes and Hospitals & Diagnostic Laboratories Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • Table 31: Europe 16-Year Perspective for Blotting Systems by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Academic & Research Institutes and Hospitals & Diagnostic Laboratories for the Years 2014, 2024 & 2030
FRANCE
  • Blotting Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2024 (E)
  • Table 32: France Recent Past, Current & Future Analysis for Blotting Systems by End-Use - Pharma & Biotech Companies, Academic & Research Institutes and Hospitals & Diagnostic Laboratories - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • Table 33: France Historic Review for Blotting Systems by End-Use - Pharma & Biotech Companies, Academic & Research Institutes and Hospitals & Diagnostic Laboratories Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • Table 34: France 16-Year Perspective for Blotting Systems by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Academic & Research Institutes and Hospitals & Diagnostic Laboratories for the Years 2014, 2024 & 2030
GERMANY
  • Blotting Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2024 (E)
  • Table 35: Germany Recent Past, Current & Future Analysis for Blotting Systems by End-Use - Pharma & Biotech Companies, Academic & Research Institutes and Hospitals & Diagnostic Laboratories - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • Table 36: Germany Historic Review for Blotting Systems by End-Use - Pharma & Biotech Companies, Academic & Research Institutes and Hospitals & Diagnostic Laboratories Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • Table 37: Germany 16-Year Perspective for Blotting Systems by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Academic & Research Institutes and Hospitals & Diagnostic Laboratories for the Years 2014, 2024 & 2030
ITALY
  • Table 38: Italy Recent Past, Current & Future Analysis for Blotting Systems by End-Use - Pharma & Biotech Companies, Academic & Research Institutes and Hospitals & Diagnostic Laboratories - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • Table 39: Italy Historic Review for Blotting Systems by End-Use - Pharma & Biotech Companies, Academic & Research Institutes and Hospitals & Diagnostic Laboratories Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • Table 40: Italy 16-Year Perspective for Blotting Systems by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Academic & Research Institutes and Hospitals & Diagnostic Laboratories for the Years 2014, 2024 & 2030
UNITED KINGDOM
  • Blotting Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2024 (E)
  • Table 41: UK Recent Past, Current & Future Analysis for Blotting Systems by End-Use - Pharma & Biotech Companies, Academic & Research Institutes and Hospitals & Diagnostic Laboratories - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • Table 42: UK Historic Review for Blotting Systems by End-Use - Pharma & Biotech Companies, Academic & Research Institutes and Hospitals & Diagnostic Laboratories Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • Table 43: UK 16-Year Perspective for Blotting Systems by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Academic & Research Institutes and Hospitals & Diagnostic Laboratories for the Years 2014, 2024 & 2030
SPAIN
  • Table 44: Spain Recent Past, Current & Future Analysis for Blotting Systems by End-Use - Pharma & Biotech Companies, Academic & Research Institutes and Hospitals & Diagnostic Laboratories - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • Table 45: Spain Historic Review for Blotting Systems by End-Use - Pharma & Biotech Companies, Academic & Research Institutes and Hospitals & Diagnostic Laboratories Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • Table 46: Spain 16-Year Perspective for Blotting Systems by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Academic & Research Institutes and Hospitals & Diagnostic Laboratories for the Years 2014, 2024 & 2030
RUSSIA
  • Table 47: Russia Recent Past, Current & Future Analysis for Blotting Systems by End-Use - Pharma & Biotech Companies, Academic & Research Institutes and Hospitals & Diagnostic Laboratories - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • Table 48: Russia Historic Review for Blotting Systems by End-Use - Pharma & Biotech Companies, Academic & Research Institutes and Hospitals & Diagnostic Laboratories Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • Table 49: Russia 16-Year Perspective for Blotting Systems by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Academic & Research Institutes and Hospitals & Diagnostic Laboratories for the Years 2014, 2024 & 2030
REST OF EUROPE
  • Table 50: Rest of Europe Recent Past, Current & Future Analysis for Blotting Systems by End-Use - Pharma & Biotech Companies, Academic & Research Institutes and Hospitals & Diagnostic Laboratories - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • Table 51: Rest of Europe Historic Review for Blotting Systems by End-Use - Pharma & Biotech Companies, Academic & Research Institutes and Hospitals & Diagnostic Laboratories Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • Table 52: Rest of Europe 16-Year Perspective for Blotting Systems by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Academic & Research Institutes and Hospitals & Diagnostic Laboratories for the Years 2014, 2024 & 2030
ASIA-PACIFIC
  • Blotting Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2024 (E)
  • Table 53: Asia-Pacific Recent Past, Current & Future Analysis for Blotting Systems by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
  • Table 54: Asia-Pacific Historic Review for Blotting Systems by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • Table 55: Asia-Pacific 16-Year Perspective for Blotting Systems by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2014, 2024 & 2030
  • Table 56: Asia-Pacific Recent Past, Current & Future Analysis for Blotting Systems by End-Use - Pharma & Biotech Companies, Academic & Research Institutes and Hospitals & Diagnostic Laboratories - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • Table 57: Asia-Pacific Historic Review for Blotting Systems by End-Use - Pharma & Biotech Companies, Academic & Research Institutes and Hospitals & Diagnostic Laboratories Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • Table 58: Asia-Pacific 16-Year Perspective for Blotting Systems by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Academic & Research Institutes and Hospitals & Diagnostic Laboratories for the Years 2014, 2024 & 2030
AUSTRALIA
  • Blotting Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2024 (E)
INDIA
  • Blotting Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2024 (E)
SOUTH KOREAREST OF ASIA-PACIFIC
LATIN AMERICA
  • Blotting Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2024 (E)
ARGENTINABRAZILMEXICOREST OF LATIN AMERICA
MIDDLE EAST
  • Blotting Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2024 (E)
IRANISRAELSAUDI ARABIAUNITED ARAB EMIRATESREST OF MIDDLE EAST
AFRICA
  • Blotting Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2024 (E)
IV. COMPETITION

Companies Mentioned (Partial List)

A selection of companies mentioned in this report includes, but is not limited to:

  • Advansta Inc.
  • Bio-Rad Laboratories, Inc.
  • Bio-Techne Coporation
  • Cell Signaling Technology, Inc.
  • F. Hoffmann-La Roche AG
  • GE Healthcare
  • LI-COR, Inc. (LI-COR Biosciences)
  • Merck KgaA
  • PerkinElmer, Inc.
  • Thermo Fisher Scientific, Inc.

Table Information